Genetics. FDA races in wrong direction.

Journal Article (Journal Article)

Despite recent genetic evidence and the promise of individualized medicine, there is a continuing interest in using self-identified categories of race and ethnicity as variables in scientific and medical research. The U.S. Food and Drug Administration recently proposed a standardized approach for the collection of race and ethnicity data in clinical trials. We believe that this move fails to acknowledge new scientific data and recommend that relevant data from individuals be collected and used rather than broad group statistics. We also encourage that increased funding be committed to this important issue.

Full Text

Duke Authors

Cited Authors

  • Haga, SB; Venter, JC

Published Date

  • July 25, 2003

Published In

Volume / Issue

  • 301 / 5632

Start / End Page

  • 466 -

PubMed ID

  • 12881555

Electronic International Standard Serial Number (EISSN)

  • 1095-9203

Digital Object Identifier (DOI)

  • 10.1126/science.1087004


  • eng

Conference Location

  • United States